Phase II trial of NEU 2000 in patients with ischaemic stroke.
Phase of Trial: Phase II
Latest Information Update: 05 May 2008
At a glance
- Drugs NEU 2000 (Primary)
- Indications Stroke
- Focus Therapeutic Use
- Sponsors AmKor Pharma
- 05 May 2008 New trial record.
- 23 Apr 2008 AmKor stated in a media release that this trial will be initiated in 2008.